Tags: Novo Nordisk

Novo Nordisk’s Obesity Drug CagriSema Hits 20% Weight Loss Mark

Ozempic Maker Novo Nordisk to Cut 9,000 Jobs Amid Rising Competition in Obesity Market

Novo Nordisk will cut 9,000 jobs to refocus on obesity and diabetes treatments amid rising competition from rivals like Eli Lilly.


Novo Nordisk's Wegovy Delivers Positive Heart Results Amid Sales Struggles

Novo Nordisk's Wegovy shows a 57% lower risk of heart attack and stroke in new study, boosting its edge over Eli Lilly.

Novo Nordisk Halts Wegovy Sales on Hims & Hers, Citing FDA Violations

Novo Nordisk ends partnership with Hims & Hers over concerns about unsafe Wegovy sales and FDA violations.

Novo Nordisk's Obesity Drug CagriSema Hits 20% Weight Loss Mark in Late-Stage Trial

Novo Nordisk's CagriSema helps patients lose over 20% body weight in late-stage obesity trial.


Latest News

Weight-Loss Drug Wegovy Approved For Heart Health Under Medicare Despite
Novo Nordisk launches Wegovy in China, offering an effective weight-loss solution for about 180 million obese Chinese population, though not covered by insurance.
GLP-1 Treatments Like Ozempic Reduce Risk of Obesity-Related Cancers in Type 2 Diabetes Patients: Study
A new study reveals that semaglutide, a key ingredient in Ozempic and Wegovy, reduces the risk of dying from Covid-19 by 33%, [otentially boosting its market value.
Novo Nordisk, Eli Lilly Shares Decrease After Roche Reveals Obesity Drug Trial
Shares of pharmaceutical companies Novo Nordisk and Eli Lilly slid after Roche announced results from a promising early-stage trial for its proposed obesity drug.
Ozempic, Wegovy Users May Face Rare Blindness Risk, Study Suggests Further Investigation Needed
A new study published in JAMA Ophthalmology suggests that taking Ozempic or Wegovy may increase the risk of developing a rare form of blindness.
Joe Biden, Bernie Sanders Urge Novo Nordisk and Eli Lilly to Lower Prices of Weight Loss Drugs
President Joe Biden and Senator Bernie Sanders have urged Novo Nordisk and Eli Lilly to lower the prices of their popular weight loss drugs.
Novo Nordisk Announces $4.1 Billion Investment in North Carolina for Wegovy and Ozempic Production Boost
Novo Nordisk announced a $4.1 billion investment to build a new manufacturing plant in Clayton, North Carolina, to increase production capacity for its popular drugs Wegovy, Ozempic, and other injectable therapies.
Novo Nordisk CEO to Testify Before Senate After Sanders' Subpoena Threat Over Drug Pricing
Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate following Sen. Bernie Sanders' threat to subpoena the company over the pricing of diabetes drug Ozempic and obesity drug Wegovy.
Obesity Drug Wegovy Reduces Risk of Heart Attack, Stroke, Despite Not Contributing Much to Patient’s Weight Loss, Study Finds
Telehealth startup Ro has launched a free online tracker to help patients and doctors locate in-stock weight-loss drugs like Wegovy amid national shortages, providing real-time availability and the option to report outages to the FDA.
Amgen
Amgen witnessed an impressive 12% surge in its shares on Friday, marking its most substantial single-day increase in nearly 15 years.
Bill Gates
The Bill & Melinda Gates Foundation, Novo Nordisk Foundation, and Wellcome Trust collaborated to solve global health concerns using science and technology.
1 2